hotspot -WSS

hotspot

author：leisure time 2025-09-28 07:22:07 - browse：156

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Virginia high school admissions case could be legal follow
Next article： Christmas in the PICU brings some surprising joy

leisure time

entertainment

WSS

What causes osteoarthritis? Researchers study link to brain protein

Hospitals owned by private equity see complications spike 25%

Maisha Meds is a PBM, but don't call it that

Albert Bourla of Pfizer: worst biopharma CEO of 2023

HCA sued by state AG for quality issues at Mission Health

Microsoft launches AI tool for clinical documentation through Epic

focus

hotspot

hotspot

Affirmative action in medical school literally saved lives

The inclusion problem at the heart of rehabilitation research

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

How to save PrEP access — and even expand it

Cardiologists urge adding sexual orientation, gender identity to health records

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare drug price lawsuits could be good politics for Biden

Continuity nursing helped my family in our darkest PICU moments

Prior authorization reform is both possible and imperative

hotspot

Future doctors need a strong humanities education

Dana Farber says 6 studies to be retracted and 31 corrected

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

FDA sets aggressive timeline for overhauling inspection procedures

A pediatrician calls for Congress to pass the child tax credit deal

A pediatrician calls for Congress to pass the child tax credit deal

leisure time

entertainment

leisure time

hotspot